Revvity Omics Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Revvity omics lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Revvity Omics Lab Today - Breaking & Trending Today

Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript

Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript April 29, 2024 Revvity, Inc. beats earnings expectations. Reported EPS is $0.98, expectations were $0.94. Revvity, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to the Q1 2024 […] ....

Max Krakowiak , Our Life Sciences Instrument , Tour Life Sciences , Specialty Pharma Services , Life Sciences , Reagents Technology Licensing , Our Signal Software , Revvity Omics Lab , Investor Relations , Life Sciences Instrument , Signal Software , Newborn Screening , Applied Genomics , Steve Willoughby , Prahlad Singh , Newborn Screening ,

Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript

Revvity, Inc. beats earnings expectations. Reported EPS is $0.98, expectations were $0.94. Revvity, Inc. ....

San Diego , United States , Joshua Waldman , Michael Ryskin , Vijay Kumar , Max Krakowiak , Josh Waldman , Oxford Immunotec , Steve Willoughby , Andrew Cooper , Raymond James , Doug Schenkel , Patrick Donnelly , Jack Meehan , Prahlad Singh , Matt Sykes , Matthew Sykes , Nephron Research , Cleveland Research , Life Sciences Reagents , Life Sciences , Our Life Sciences Instrument , Revvity Omics Lab , Life Sciences Or Applied Genomics , Revvity Signals Software , Reagents Technology Licensing ,